Financial Daily from THE HINDU group of publications
Thursday, Dec 18, 2003
Financial Daily from THE HINDU group of publications Thursday, Dec 18, 2003 |
|
|
|
|
|
Marketing
-
New Products & Services Corporate - Announcements Industry & Economy - Health Natco Pharma unveils two more anti-cancer drugs Our Bureau
Hyderabad , Dec 17 NATCO Pharma Ltd (NPL), a city-based pharmaceutical company, has announced the launch of two more anti-cancer drugs - Natfost (amifostine injection) and Hyurea (hydroxyurea capsules). In a release on Tuesday, NPL said that Natfost selectively protects normal cells from certain side effects of chemotherapy and radiation. Hyurea is used in the treatment of leukaemia, melanoma and colon carcinoma. Given orally in combination with other drugs or radiation, it prevents the cancer cells from progressing at one stage of growth to another, resulting in their death. Used in combination with radiation, Hyurea prevents the cancer cell from repairing itself.With these launches, NPL claims to have established itself a major player in the oncology segment with a basket of about 10 drugs. It expects to consolidate its position in the oncology segment.
Article E-Mail :: Comment :: Syndication
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |
Copyright © 2003, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|